Explore the science behind zoledronic acid, its FDA approval for treating multiple myeloma and cancer bone metastases, and its transformative impact on patient care.
Discover how scientists determined the optimal denosumab dose regimen through pharmacokinetic and pharmacodynamic analysis in breast cancer patients with bone metastases.